Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib
Clinical trial NCT00441155 · COMPLETED
Trial details
- NCT number
- NCT00441155
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2011-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.